We presented a new lecture in a local French Anti-Aging Congress near Toulouse last week. Demonstration of different Carboxytherapy devices and new CO2 indications. A special training room was set to teach over 30 MD how to start a CO2 therapy activity.
Last Updated on Friday, 11 February 2011 11:38
SKIN-Breath invention at EMMA Paris
Written by Administrator
Thursday, 21 October 2010 10:06
Skin Breath, the ultraportable carboxytherapy device was exposed the EMAA with a great success. Man MD got their model from the Booth and brought them home (USA, Russia, Poland, South America, Middle East...).
Photo of Kairos Medical Booth showing the complete Skin-Breath collection.
Last Updated on Thursday, 21 October 2010 12:22
Small and portable Carboxytherapy equipment.
Written by Administrator
Tuesday, 08 June 2010 08:49
A new product has been released in the Carboxytherapy world. Carboxyworld's team was involved in this invention project: making the first safe & sterilizable CO2 medical device any MD can afford to discover carboxytherapy with the minimum expense and the best return on investment. In this video, you may now see the final result in production: an ultraportable system working with CO2 medical grade cartridges.
Skin Breath Ultraportable Carboxytherapy equipment in Hong-Kong Imcas congress in July
Written by Administrator
Tuesday, 08 June 2010 08:28
The Carboxyworld team will flight to Hong-Kong IMCAS (July the 10-11-12). We will show our new Skin Breath micro-portable carboxytherapy unit at low cost & high efficiency. Note to all those who will attend the Congres, we will organize a contest. The winning prize is a Skin-Breath (Commercial value : 1500 EUR, 1700 US$).
Last Updated on Tuesday, 08 June 2010 08:53
Carbon Dioxide Therapy in the Treatment of Cellulite: An Audit of Clinical Practice
The clinical practice of using carbon dioxide therapy for localized adiposities was audited over a 4-year period.
Methods
Patients receiving physical, dietary, or drug concurrent therapy were excluded from the audit. Original measurements in terms of mean ± standard error of the mean (SEM) were compared with those obtained after five sessions.
Results
This series included 101 women who underwent abdominal therapy. Significant reduction (p < 0.05) in mean upper, mid, and lower abdomen circumference was experienced by all three age groups: respectively, 1.8 ± 0.5, 1.6 ± 0.4, and 2.1 ± 0.3 cm in the 20- to 29-year- old group, 1.6 ± 0.4, 2.3 ± 0.3, and 2.1 ± 0.3 cm in the 30- to 39-year-old group, and 2.0 ± 0.4, 2.5 ± 0.4, and 2.6 ± 0.4 cm in the 40- to 50-year-old group. For 57 women who underwent localized thigh therapy (27 in the 20- to 29-year-old group, 18 in the 30- to 39-year-old group, and 12 in the 40- to 50-year-old group), thigh circumference was significantly reduced in the right versus left thigh: respectively, 1.6 ± 0.3 versus 1.5 ± 0.2 cm, 1.1 ± 0.3 versus 1.1 ± 0.3 cm, 1.6 ± 0.3 versus 1.5 ± 0.4. Weight loss was significant for older women who underwent abdominal therapy: 1.3 ± 0.2 kg in the 30- to 39-year-old group (n = 43) and 1.3 ± 0.2 kg in the 40- to 50 year-old group (n = 29). Older women who underwent thigh therapy also recorded significant weight reduction: 0.9 ± 0.4 kg in the 30- to 39-year-old group (n = 18) and 1.6 ± 0.3 kg in the 40- to 50-year-old group (n = 12). The results for 10 men were not significant.
Conclusion
These results agree with those reported originally and demonstrate that carboxytherapy is safe and effective.
New Carboxytherapy lecture in Toulouse last week
The Carboxyworld team will flight to